Patents by Inventor Alan Winter
Alan Winter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 6265581Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective &bgr;3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: April 17, 2000Date of Patent: July 24, 2001Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
-
Patent number: 6164966Abstract: A method and device for the high speed fluid (preferably water) jet removal of dental caries. The water jet is of a controlled upper and lower speed and pressure with a low speed and pressure being of at least 5 to 10 kpsi, sufficient to pierce and flush decayed tissue of a caries with a small beam fluid jet diameter. A pulsed or continuous fluid jet is used to remove and completely flush caries material from a tooth in a time period of under a second with a maximum stagnation pressure of about 30 kpsi, at which point healthy dentin is affected. A coherent or pseudo-coherent water jet operating at high stagnation pressure (range 10,000 to 20,000-psi and no more than 30-kpsi), in a brief burst (.apprxeq.1 second) and small beam diameter (30 to 100-.mu.m) will cleanly remove caries without damage to the tooth structure in particular the sound dentin at the boundary of the caries. No anaesthetic is accordingly required in the absence of a possible exposed nerve.Type: GrantFiled: March 17, 1999Date of Patent: December 26, 2000Assignee: Medjet, Inc.Inventors: Parid Turdiu, Eugene Irving Gordon, Joel Hasen, Ronald B. Odrich, Alan A. Winter
-
Patent number: 6133458Abstract: The invention provides benzo[b]indenothiophene compounds, intermediates, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.Type: GrantFiled: September 30, 1998Date of Patent: October 17, 2000Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Brian Stephen Muehl, Mark Alan Winter
-
Patent number: 6093735Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: July 1, 1999Date of Patent: July 25, 2000Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
-
Patent number: 6075040Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: May 2, 1997Date of Patent: June 13, 2000Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Cynthia Darshini Jesudason, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
-
Patent number: 6060492Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formula II: ##STR1## The variables in Formula II are defined herein.Type: GrantFiled: June 25, 1997Date of Patent: May 9, 2000Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Anthony John Shuker, Mark Alan Winter
-
Patent number: 6040927Abstract: Different print quality modes in a printer such as a color inkjet printer invoke different print rendering options for a particular object to be printed. In an exemplary embodiment, a printer control automatically invokes an error diffusion haltoning technique for photo images whenever high quality mode is designated, and automatically invokes a dither haltoning technique for photo images whenever a normal or fast print mode is designated.Type: GrantFiled: December 4, 1996Date of Patent: March 21, 2000Assignee: Hewlett-Packard CompanyInventors: Kirt Alan Winter, Thomas G. Smith
-
Patent number: 6015207Abstract: Different print quality modes in a printer such as a color inkjet printer invoke different print rendering options for a particular object to be printed. In an exemplary embodiment, a printer control automatically invokes an error diffusion haltoning technique for photo images whenever high quality mode is designated, and automatically invokes a dither haltoning technique for photo images whenever a normal or fast print mode is designated.Type: GrantFiled: January 21, 1999Date of Patent: January 18, 2000Assignee: Hewlett-Packard CompanyInventors: Kirt Alan Winter, Thomas G. Smith
-
Patent number: 5977154Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: June 26, 1997Date of Patent: November 2, 1999Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Christine Ann Droste, Cynthia Darshini Jesudason, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
-
Patent number: 5939443Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity. The invention provides compounds and method of treating type II diabetes, comprising administering to a mammal in need thereof compounds of the Formula II: ##STR1## The variables in Formula II are defined herein.Type: GrantFiled: June 25, 1997Date of Patent: August 17, 1999Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Donald Paul Matthews, John Hampton McDonald, III, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
-
Patent number: 5867633Abstract: The present invention relates to a method and system for efficient image handling. The invention includes an image server with which image files are registered. The image processing requests are sent to the image server to produce image data representing the processed image file. In one embodiment of the invention, a document processing application obtains an image file for printing. The application registers the image with the image server. The image server returns an identifier identifying the image file which is used for subsequent image processing requests. The application initiates a print job, sending the image identifier and selected print parameters to a printer driver. In response, the printer driver negotiates image processing requests with the image server to modify the image file in accordance with the selected print parameters. Finally, the processed image data is retrieved from the image server and sent to the printer.Type: GrantFiled: December 9, 1996Date of Patent: February 2, 1999Assignee: Hewlett-Packard CompanyInventors: Robert B. Taylor, III, Kirt Alan Winter, Robert Chou, Sachin Naik
-
Patent number: 5856341Abstract: The invention provides benzo?b!indenothiophene compounds of formula I ##STR1## wherein, R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, and R.sup.6, are as defined in the specification, intermediates, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.Type: GrantFiled: September 19, 1997Date of Patent: January 5, 1999Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Brian Stephen Muehl, Mark Alan Winter
-
Patent number: 5840738Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: June 25, 1997Date of Patent: November 24, 1998Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Christine Ann Droste, Cynthia Darshini Jesudason, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Christopher John Rito, Anthony John Shuker, Mark Alan Winter
-
Patent number: 5834488Abstract: The invention provides dihydrobenzo?b!indenothiophene compounds, intermediates, processes, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.Type: GrantFiled: September 19, 1997Date of Patent: November 10, 1998Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Brian Stephen Muehl, Mark Alan Winter
-
Patent number: 5808080Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: May 2, 1997Date of Patent: September 15, 1998Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, David Andrew Neel, Mark Alan Winter
-
Patent number: 5786356Abstract: The present invention is in the field of medicine, particularly in the treatment of Type II diabetes and obesity. More specifically, the present invention relates to selective .beta.3 adrenergic receptor agonists useful in the treatment of Type II diabetes and obesity.Type: GrantFiled: June 25, 1997Date of Patent: July 28, 1998Assignee: Eli Lilly and CompanyInventors: Michael Gregory Bell, Thomas Alan Crowell, Donald Paul Matthews, John Hampton McDonald, III, David Andrew Neel, Anthony John Shuker, Mark Alan Winter
-
Patent number: 5768482Abstract: Method and apparatus prepare an image for printing--and in some cases include an output stage, performing the actual printing--when the overall number of pixels is being scaled up or down from an original image or portion. Image-sharpening procedures are controlled automatically by a function of the number of pixels in the original image and the number in the output device. Any of a great variety of such functions may be used, but we prefer a step-function of a ratio of the two pixel counts--particularly a two-valued step-function in which one value is zero and the other serves as a sharpening factor in a sharpening algorithm. When the function yields its zero value, for efficiency the sharpening computations are preferably turned off. The nonzero value is automatically selected when the number of output pixels is more than twice the number of input pixels. The sharpening-factor value, ideally two, is multiplied by the deviation of each image element, e. g.Type: GrantFiled: June 14, 1995Date of Patent: June 16, 1998Assignee: Hewlett-Packard CompanyInventors: Kirt Alan Winter, Frank Anthony Kurucz
-
Patent number: 5704021Abstract: A method of using a printer system for identifying one or more different types of color objects in a document, selecting a preferred rendering option such as halftoning and/or color matching for each one of such different color object types, respectively, and then printing the document in accordance with the rendering options selected for each of such different color object types. In a printing system such as an inkjet color printer coupled through a printer driver to a host computer, a default halftoning technique and a default color-matching map are incorporated into the printer system for automatic invocation whenever a particular color object type is printed.Type: GrantFiled: January 27, 1994Date of Patent: December 30, 1997Assignee: Hewlett-Packard CompanyInventors: Thomas G. Smith, Kirt Alan Winter, Frank Anthony Kurucz